Shown to be effective for the vaccination of healthy cattle and sheep against disease caused by Clostridium chauvoei, C. septicum, C. novyi Type B, C. haemolyticum, C. tetani and C. perfringens Types C and D.
Indications
This product has been shown to be effective for the vaccination of healthy cattle and sheep against disease caused by Clostridium chauvoei, C. septicum, C. haemolyticum, C. novyi, C. tetani, and C. perfringens Type C & D.
Although C. perfringens Type B is not a significant problem in North America, immunity is derived from a combination of the Type C (beta) and Type D (epsilon) fractions.
Diseases
Clostridium chauvoei
Clostridium haemolyticum
Clostridium novyi
Clostridium perfringens C
Clostridium perfringens D
Clostridium septicum
Clostridium tetani
Dosage
CATTLE: 5 mL injection administered subcutaneously or intramuscularly followed by a second 5 mL dose given six weeks later. Revaccinate annually with 5 mL prior to periods of extreme risk or parturition.
SHEEP: 5 mL injection administered subcutaneously followed by a second 2 mL dose given six weeks later. Revaccinate annually with 2 mL prior to periods of extreme risk or parturition.
Preservative
Contains Thimerosal as a preservative.
Caution
Store at 2°-8°C (35°-46°F). Do not freeze. Use entire contents when first opened. Do not mix with other products. Do not vaccinate within 21 days before slaughter. This product has not been tested in pregnant cattle. Local reactions may be observed following subcutaneous administration to cattle. Anaphylactoid reactions may occur following use. Antidote: Epinephrine. In case of human exposure, contact a physician.
FOR ANIMAL USE ONLY.
U.S. only: Merck Animal Health livestocktechsrvc@merck-animal-health.com or call 1-800-211-3573
For more information regarding efficacy and safety data, go to productdata.aphis.usda.gov
For additional information, please see the product label.
